Engineered Probiotic Bacteria Boost Immune Attack Against Pancreatic Cancer

Engineered Probiotic Bacteria Boost Immune Attack Against Pancreatic Cancer

Researchers have discovered that engineered probiotic bacteria can boost the immune system's attack against pancreatic cancer. The study found that the bacteria can stimulate the immune system to produce more cancer-fighting cells. The researchers used a combination of probiotic bacteria and a cancer-fighting protein to create a treatment that can target pancreatic cancer cells. The study was conducted on mice and found that the treatment was effective in reducing the growth of pancreatic cancer cells. The researchers believe that this treatment has the potential to be used in humans to treat pancreatic cancer. The study was published in the journal Nature Medicine.